Moksisilit
(Preusmjereno sa stranice VRYMTAVOXVTQEF-UHFFFAOYSA-N)
Moksisilit (timoksamin) je lek koji se koristi u urologiji za tretman erektilne disfunkcije. On je antagonist α1-adrenergičkog receptora.[4]
| |||
| (IUPAC) ime | |||
|---|---|---|---|
| 4-[2-(Dimetilamino)etoksi]-5-izopropil-2-metilfenil acetat | |||
| Klinički podaci | |||
| AHFS/Drugs.com | Internacionalno ime leka | ||
| Identifikatori | |||
| CAS broj | 54-32-0 | ||
| ATC kod | G04BE06 C04AX10 | ||
| PubChem[1][2] | 4260 | ||
| UNII | PW8QYA7KI0 
| ||
| KEGG[3] | D08239
| ||
| Hemijski podaci | |||
| Formula | C16H25NO3 | ||
| Mol. masa | 279,375 g/mol | ||
| SMILES | eMolekuli & PubHem | ||
| |||
| Farmakoinformacioni podaci | |||
| Trudnoća | ? | ||
| Pravni status | |||
Reference uredi
- ↑ Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today 15 (23-24): 1052-7. DOI:10.1016/j.drudis.2010.10.003. PMID 20970519.
- ↑ Evan E. Bolton, Yanli Wang, Paul A. Thiessen, Stephen H. Bryant (2008). „Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities”. Annual Reports in Computational Chemistry 4: 217-241. DOI:10.1016/S1574-1400(08)00012-1.
- ↑ Joanne Wixon, Douglas Kell (2000). „Website Review: The Kyoto Encyclopedia of Genes and Genomes — KEGG”. Yeast 17 (1): 48–55. DOI:10.1002/(SICI)1097-0061(200004)17:1<48::AID-YEA2>3.0.CO;2-H.
- ↑ Sakakibara R, Hattori T, Uchiyama T, et al. (March 2000). „Are alpha-blockers involved in lower urinary tract dysfunction in multiple system atrophy? A comparison of prazosin and moxisylyte”. J. Auton. Nerv. Syst. 79 (2–3): 191–5. DOI:10.1016/S0165-1838(99)00105-8. PMID 10699651.
